Home › Big Pharma

Big Pharma

News Story
11/7/2016
Posted by Mark Reback
This year, Mary O’Connor and her father made voting a family affair. O’Connor’s father is a Vietnam veteran, so she was especially interested in his views on Proposition 61, a California ballot measure that would peg the state’s payments for prescription drugs to prices paid by the Department of Veterans Affairs. It’...
Blog Post
11/7/2016
Posted by Jamie Court
Bernie Sanders came to Los Angeles’s Pershing Square today to tell Californians not to be deceived by the $130 million drug companies have spent against Prop 61’s controls on California drug prices. “Drug companies are spending over $130 million to defeat this initiative and to make certain the people of California and the...
News Release
11/2/2016
Posted by Jamie Court
Santa Monica, CA -- In the final days of the election campaign, and as the pharmaceutical industry expands its spending against Prop 61 to a record $126 million, Wall Street analysts’ private research on Proposition 61 finds that drug companies will take modest profit hits if it passes but that the industry will remain relatively unscathed....
News Story
10/21/2016
Posted by Mark Reback
Prescription drug prices in the United States are the highest in the world — by far. Californians on Nov. 8 have a chance to stand up to the pharmaceutical industry’s greed and spark a national movement to end this price-gouging. Today, no laws prevent drug companies from doubling or tripling prices. So they just do it. The most recent...
News Release
10/20/2016
Posted by Mark Reback
Santa Monica, CA -- Drug companies poured $22 million more into their campaign to stop drug pricing reform Proposition 61 after Wall Street began to query the companies about losing the election. For the first time, Proposition 61 was mentioned in an earnings call by a major drug company on October 18th. On the call, Goldman Sachs analyst Jami...
News Release
10/10/2016
Posted by Carmen Balber
Santa Monica, CA – After news broke Friday that Mylan must pay $465 million for overcharging Medicaid for the EpiPen, mothers whose children rely on the life-saving allergy drug denounced drug company greed, and called on voters to pass Proposition 61 to stop drug company price-gouging and save lives. Consumer Watchdog released an analysis...
News Story
10/8/2016
Posted by Mark Reback
The auto-injector's manufacturer agrees to pay $465 million after an 'investigation' of less than two weeks Some would say that Mylan Pharmaceuticals has been slow to satisfy consumer calls for price rollbacks on the EpiPen auto-injector. But Mylan wasted no time reaching a settlement over the issue of whether it had overcharged ...
News Release
10/4/2016
Posted by Jamie Court
Santa Monica, CA—Consumer Watchdog today called out the Kaiser Family Foundation for holding a one-sided debate on drug price controls tomorrow that allows the opponents of Prop 61, the drug makers who raised $90 million against the effort to rein in California’s drug bills, a seat but leaves proponents out. The drug-pricing panel...
Blog Post
9/27/2016
Posted by Jamie Court
You have to have the deepest respect for the women and men who serve our nation and put their lives on the line for Americans. That’s why it’s particularly galling when a Sacramento lobbyist profits by making money from drug companies under their name. The latest episode is in the fight over Prop 61, which reins in drug company...
Video
9/20/2016
Posted by Mark Reback
Our Executive Director Carmen Balber speaks at a rally for #YesonProp61 in Downtown L.A.: "This issue is not going to change in Sacramento, it’s not going to change in Washington, D.C., it’s going to change because the voters take to the street and say no more, and force Pharma to lower prescription drug prices!" #...